estradiol 2mg / dydrogesterone 10mg tablets
de pharmaceuticals - dydrogesterone; estradiol - oral tablet - 10mg ; 2mg
estradiol 2mg / dydrogesterone 10mg tablets
waymade healthcare plc - dydrogesterone; estradiol - oral tablet - 10mg ; 2mg
duphaston 10 mg tabl.
theramex ireland ltd. - dydrogesterone 10 mg - tablet - 10 mg - dydrogesterone 10 mg - dydrogesterone
femoston low 0.5 mg - 2.5 mg film-coat. tabl.
theramex ireland ltd. - dydrogesterone 2,5 mg; estradiol hemihydrate 0,517 mg - eq. estradiol 0,5 mg - film-coated tablet - 0,5 mg - 2,5 mg - dydrogesterone 2.5 mg; estradiol hemihydrate 0.517 mg - dydrogesterone and estrogen
femoston low 0,5 mg - 2,5 mg film-coated tablet
orifarm - dydrogesterone; estradiol hemihydrate - film-coated tablet - 0,5 mg - 2,5 mg - dydrogesterone 2.5 mg; estradiol hemihydrate - dydrogesterone and estrogen
femoston-conti 1mg/5mg milligram film coated tablet
abbott healthcare products ltd - estradiol dydrogesterone - film coated tablet - 1mg/5mg milligram
femoston-conti 0.5/2.5 milligram film coated tablet
abbott healthcare products ltd - estradiol dydrogesterone - film coated tablet - 0.5/2.5 milligram
femurest-conti 1/5 milligram film coated tablet
abbott healthcare products ltd - estradiol hemihydrate dydrogesterone - film coated tablet - 1/5 milligram
femoston-conti 1mg/5mg milligram film coated tablet
bgp products ltd - estradiol, dydrogesterone - film coated tablet - 1mg/5mg milligram - progestogens and estrogens, fixed combinations - : genito urinary system and sex hormones, progestogens and oestrogens, fixed combinations - hormone replacement therapy (hrt) for oestrogen deficiency symptoms in postmenopausal women at least 12 months since last menses. prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis
femoston-conti 0.5mg/2.5mg tablets
viatris uk healthcare ltd - estradiol; dydrogesterone - oral tablet - 500microgram ; 2.5mg